Latest Vivo Capital, LLC Stock Portfolio

Vivo Capital, LLC Performance:

2025 Q4: 56.96%YTD: 125.64%2024: 7.37%

Performance for 2025 Q4 is 56.96%, and YTD is 125.64%, and 2024 is 7.37%.

About Vivo Capital, LLC and 13F Hedge Fund Stock Holdings

Vivo Capital, LLC is a hedge fund based in Palo Alto, CA. On 2026-02-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, Vivo Capital, LLC reported an equity portfolio of $1.5 Billions as of 31 Dec, 2025.

The top stock holdings of Vivo Capital, LLC are TERN, CDTX, PRAX. The fund has invested 14% of it's portfolio in TERNS PHARMACEUTICALS INC and 13.7% of portfolio in CIDARA THERAPEUTICS, INC.

The fund managers got completely rid off VERONA PHARMA PLC (VRNA), TOURMALINE BIO INC. and AKERO THERAPEUTICS INC (AKRO) stocks. They significantly reduced their stock positions in SOLENO THERAPEUTICS INC (SLNO), BOLT THERAPEUTICS INC (BOLT) and VERASTEM INC (VSTM). Vivo Capital, LLC opened new stock positions in ALTO NEUROSCIENCE INC, MINERVA NEUROSCIENCES INC (NERV) and DESIGN THERAPEUTICS INC (DSGN). The fund showed a lot of confidence in some stocks as they added substantially to TANGO THERAPEUTICS INC (TNGX), DBV TECHNOLOGIES SA (DBVT) and PRAXIS PRECISION MEDICINES (PRAX).

Vivo Capital, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Vivo Capital, LLC made a return of 56.96% in the last quarter. In trailing 12 months, it's portfolio return was 125.64%.

Performance
S&P 500

New Buys

Ticker	$ Bought
alto neuroscience inc	18,432,800
minerva neurosciences inc	17,377,400
design therapeutics inc	15,129,000
moonlake immunotherapeutics	13,180,000
palisade bio inc	5,389,910
pasithea therapeutics corp	2,709,000
engene holdings inc	843,736

New stocks bought by Vivo Capital, LLC

Additions

Ticker	% Inc.
tango therapeutics inc	177
dbv technologies sa	133
praxis precision medicines	65.36
camp4 therapeutics inc	8.29

Additions to existing portfolio by Vivo Capital, LLC

Reductions

Ticker	% Reduced
soleno therapeutics inc	-60.72
bolt therapeutics inc	-58.87
verastem inc	-58.17
olema pharmaceuticals inc	-55.38
oric pharmaceuticals inc	-32.25
zenas biopharma inc	-27.87
cidara therapeutics, inc.	-27.05
terns pharmaceuticals inc	-22.46

Vivo Capital, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
rezolute inc	-19,856,900
astria therapeutics inc	-11,303,500
verona pharma plc	-148,693,000
tourmaline bio inc.	-28,309,700
delcath systems, inc.	-6,122,400
akero therapeutics inc	-20,639,000
89bio inc	-5,539,020

Vivo Capital, LLC got rid off the above stocks

Sector Distribution

Vivo Capital, LLC has about 80% of it's holdings in Healthcare sector.

Sector	%
Healthcare	80
Others	20

Market Cap. Distribution

Vivo Capital, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
MID-CAP	52.6
SMALL-CAP	20.6
UNALLOCATED	20
MICRO-CAP	5.5
NANO-CAP	1.3

Stocks belong to which Index?

About 43.9% of the stocks held by Vivo Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	56.1
RUSSELL 2000	43.9

Top 5 Winners (%)		%
TERN	terns pharmaceuticals inc	388.8 %
PRAX	praxis precision medicines	192.5 %
COGT	cogent biosciences inc	137.1 %
CDTX	cidara therapeutics, inc.	113.0 %
OLMA	olema pharmaceuticals inc	112.3 %

Top 5 Winners ($)		$
TERN	terns pharmaceuticals inc	201.3 M
CDTX	cidara therapeutics, inc.	141.9 M
PRAX	praxis precision medicines	63.8 M
COGT	cogent biosciences inc	54.9 M
SABS	sab biotherapeutics inc	19.8 M

Top 5 Losers (%)		%
TIL	instil bio inc	-38.4 %
ORIC	oric pharmaceuticals inc	-26.7 %
DTIL	precision biosciences inc	-24.6 %
SLNO	soleno therapeutics inc	-21.9 %
MNPR	monopar therapeutics inc	-20.0 %

Top 5 Losers ($)		$
SLNO	soleno therapeutics inc	-33.8 M
ORIC	oric pharmaceuticals inc	-10.0 M
VSTM	verastem inc	-2.1 M
TIL	instil bio inc	-2.0 M
MNPR	monopar therapeutics inc	-1.5 M

Vivo Capital, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Vivo Capital, LLC

Vivo Capital, LLC has 47 stocks in it's portfolio. About 60.1% of the portfolio is in top 10 stocks. SLNO proved to be the most loss making stock for the portfolio. TERN was the most profitable stock for Vivo Capital, LLC last quarter.

Last Reported on: 13 Feb, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ABEO	abeona therapeutics, inc.	0.63	1,842,750	9,711,300	unchanged	0.00

ACRS	aclaris therapeutics, inc.	1.73	8,888,890	26,755,600	unchanged	0.00

AKRO	akero therapeutics inc	0.00	0.00	0.00	sold off	-100

ATXS	astria therapeutics inc	0.00	0.00	0.00	sold off	-100

BOLT	bolt therapeutics inc	0.03	72,414	395,960	reduced	-58.87

CDTX	cidara therapeutics, inc.	13.66	956,670	211,319,000	reduced	-27.05

CMPX	compass therapeutics inc	3.31	9,545,470	51,259,200	unchanged	0.00

COGT	cogent biosciences inc	5.51	2,398,990	85,212,200	reduced	-13.99

CRVS	corvus pharmaceuticals holdings	1.11	2,234,570	17,206,200	unchanged	0.00

CTMX	cytomx therapeutics inc	0.79	2,884,620	12,288,500	unchanged	0.00

DBVT	dbv technologies sa	3.05	2,461,630	47,189,400	added	133

DCTH	delcath systems, inc.	0.00	0.00	0.00	sold off	-100

DRUG	bright minds biosciences inc	2.53	501,617	39,146,200	unchanged	0.00

DSGN	design therapeutics inc	0.98	1,612,900	15,129,000	new

DTIL	precision biosciences inc	0.00	4,675	19,449	unchanged	0.00

DYN	dyne therapeutics inc	3.31	2,614,960	51,148,600	unchanged	0.00

ERAS	erasca inc	2.23	9,273,430	34,497,200	unchanged	0.00

ETNB	89bio inc	0.00	0.00	0.00	sold off	-100

GERN	geron corp	2.32	27,225,300	35,937,400	unchanged	0.00

KTTA	pasithea therapeutics corp	0.17	2,100,000	2,709,000	new